Market Research Future

  Bioinformatics Market Trends   is the use of information technology in the field of biotechnology for the purpo s e of data storage, data warehousing, and analysing the DNA sequences. The market is going to grow at a sound pace during the forecast period. The major drivers will be the growing biotechnology sector, increasing global burden of the diseases, and increasing research and development expenses. According to the International Trade Administration, the total turnover for the biotechnology sector in the Germany reached from USD 3,280 million in 2015 to USD 3,410 million in 2016. Moreover, it was estimated that in 2016, the RD expenditure for biotech sector was about USD 1,040 million. Moreover, increasing initiatives from government and private organizations followed by improved collaborative ties between companies and research institutes fuels the market growth. However, lack of well-defined standards and common data formats for integration of data, shortage of skilled bioinf

  Market Highlights According to MRFR analysis,  Patient Blood Management Market Size  is expected to register a  CAGR of 6.48%  during the forecast period of  2019 to 2025  and was valued at  USD 10,221 Million in 2018. Patient Blood Management used to minimize blood loss during surgical operations and optimize patients’ blood. It is performed by medical practitioners for patients who have a high risk of blood loss during surgical intervention. It is majorly applicable in blood banks, hospitals, and diagnostic & pathology labs. The growth of the global patient blood management market is determined by numerous factors such as a high number of blood donations, rising prevalence of target diseases, and increasing demand for donated blood. According to the World Health Organization (WHO), about 108 million blood donations were collected globally every year. However, the high cost associated with automated systems is projected to restrain the growth of the market during the forecast pe

  Market Highlights Global  Neurorehabilitation Gaming Systems Market   is expected to register a  CAGR of 17.3%  during the forecast period, with a market value of  USD 89,361.8 Thousand by 2025. The use of gaming consoles and tablets as an adjunct to traditional rehabilitation in patients with neurological disorders is promising. They are commercially available, affordable, and safe to use in the rehabilitation of neurological conditions. The neurorehabilitation gaming system helps to improve the process of motor learning and recovery from incidents of stroke, traumatic brain injury, and other neuromuscular impairment by increasing user motivation during training. Moreover, the increasing participation of key players to perform extensive research and development activities for product launch and to gain approvals by regulatory bodies will support the growth of the global neurorehabilitation gaming systems market. For instance, in May 2018, MindMaze (Switzerland)received the US Food a

  The global  Invisible Orthodontics Market Share  is growing pervasively. The market growth majorly attributes to the rising popularity of clear aligners. Invisible orthodontics have been around for years, but they have significantly evolved over recent years, demonstrating fabulous results in teeth straightening. Among various factors, teledentistry plays a causal role in market development by offering a less costly and more convenient alternative to traditional dental care.  Due to lockdown implemented to control the COVID 19 spread, people are increasingly adopting teledentistry to straighten teeth at home comfort. And, the technology is providing uninterrupted services even during the coronavirus crises. Resultantly, the invisible orthodontics market is expected to witnesses a steady increase during the lockdown period as well. Market Research Future (MRFR), in its recent report, asserts that the already booming global invisible orthodontics market would steadily grow at 13.99% CA

  According to MRFR analysis,  Systemic Lupus Erythematosus Treatment Market Size  is expected to register a CAGR of 6% during the forecast period of 2020 to 2027 and was valued at USD 1.06 Billion in 2020. Systemic lupus erythematosus (SLE) is an autoimmune disease in which the body attacks its healthy cells. The organs affected in the disease can be joints, skin, brain, and kidney amongst others. Causes of SLE can be genetic, hormonal, environmental or side effects of other medicines. The growth of global systemic lupus erythematosus treatment market is driven by various factors such as High prevalence incidence of systemic lupus erythematosus, product launches by key players, strong product pipeline, and increasing awareness regarding systemic lupus erythematosus. However, the stringent regulatory policies and side effects of medications are expected to curb the growth of the global systemic lupus erythematosus treatment market. The global systemic lupus erythematosus treatment mark

  Market Highlights According to MRFR analysis, the global Doppler ultrasound market is expected to register a CAGR of ~7.95% during the forecast period of 2020 to 2027 and is expected to reach USD 2,800 Million by 2027. Doppler ultrasound is a test that uses high-frequency sound waves to measure the amount of blood flow through arteries and veins, usually those that supply blood to arms and legs. The growth of the   Doppler Ultrasound Device Market Share  is driven by various factors such as growing awareness among people about to early diagnosis of diseases and raised abnormalities in fetuses due to pregnancy at a later age. Increased new product launches, mergers, acquisitions and partnerships of the major players of the market. Additionally, rising innovations in the field of ultrasound by top players. However, stringent government regulations are projected to hamper the growth of the global Doppler ultrasound market. Several market players currently dominate the global Doppler ult

  Market Highlights The global  Fetal and Neonatal Care Equipment Market Size  held a market value of USD 5,103 million in 2017 and is projected to grow at a CAGR of 6.8% over the forecast period.  Technological advancements and launching new innovative devices in the fetal and neonatal care equipment market are driving the market growth. Technological advancements enable the detection of multiple compounds through neonatal dried blood specimens. After the success of newborn screening in phenylketonuria, major competitors in the newborn screening market are innovating to develop and introduce new models with significant performance improvements. The launch of improved performance instruments of mass spectroscopy and pulse oximeters are also expected to support market growth. For instance, PerkinElmer’s QSight 210 MD system launched in September 2016, utilizes tandem quadrupole analysis which provides regular robust screening along with higher sensitivity and faster scanning. Regional A

  Market Highlights It is estimated that the global  Fetal Bovine Serum Market  is expected to register a CAGR ~ 8% during the forecast period of 2018–2023. Fetal bovine serum is a key feedstock in pharmaceutical, diagnostics, biotechnology, diagnostic, and veterinary industries. The global fetal bovine serum market is expected to witness tremendous growth owing to the increase in demand from traditional users of serum is also expected to drive the market. Other key factors such as the untapped market opportunities in emerging countries, growing investments by government organizations are contributing towards the growth of the market. However, in the previous years, the serum industry is witnessing product shortage due to uncertain climatic conditions along with rising demand for beef and dairy product that has led to a radical drop in cattle herd population are few factors restraining the growth of the market. On the regional basis, the fetal bovine serum market in the Americas is pre

  Overview: The latest study conducted by Market Research Future (MRFR) reveals the global  Myasthenia Gravis Market   is set to witness 9.61% CAGR during the assessment period (2018-2023) and surpass a valuation of USD 3,000 Mn.  Factors such as increased prevalence rate, investment in R&D and advances in healthcare are likely to support the growth of the market. In recent years, a sharp rise in MG and related incidences has been noticed. In advanced countries, a greater level of awareness prevails, which is favoring the market’s growth. It is understood that early diagnosis and treatment can reduce the impact of the condition to a significant extent, however outcomes may vary from case to case. Advances in technology has resulted in development of therapeutics that are more effective as compared to traditional medicines. At the same time, increased level of awareness among patients and government support in product research & development is expected to create market opportuni

  ENT conditions are common across the globe. Some of the common ENT conditions include nasal polyps, hearing loss, muscle tension dysphonia, sinusitis and vocal fold paralysis.  Many of the ENT conditions require the patient to use ENT device for treatment or assistance. Improving reimbursement policies in healthcare in both advanced and developing countries is having positive influence on the global  ENT Devices Market Size . Other factors that are influencing the market include rising geriatric population, growing prevalence of chronic sinusitis, arrival of minimally invasive ENT procedures and increased cosmetic ENT procedures. Segmental Overview  MRFR’s report covers a detailed segmental analysis of the Global  ENT Systems  on basis of end user, product and region.  By end user, the market has been segmented into ambulatory settings, research and academic institutes, hospitals, home care settings, ENT clinics, and others. Based on product, the market has been segmented into surgic

  The Global  Oncology Information Systems (OIS) Market  held a market value of USD 2,356.6 million in 2020 and is projected to grow at a CAGR of 7.5% over the forecast period . OIS is a complete information and image management solution that enables the management of patient treatment schedules, treatment plans, treatment delivery, and treatment summaries. Overall, this system allows healthcare professionals to oversee all aspects of oncology care for their patients. Factors accounted for the market growth are globally growing older population coupled with rising incidence of cancer, the presence of favorable government initiatives, mounting investments in cancer research, and technological advancements in OIS. In contrast, higher costs associated with OIS services are anticipated to hinder the market growth during the forecast period from 2020 to 2027. Regional Analysis: The Global Oncology Information Systems Market has been segmented by region into the Americas, Europe, Asia-Pacifi

  Market Overview Market Research Future (MRFR) predicts the global blood screening market to achieve a CAGR of 9.8% during the forecast period (2018–2023).  Market Boosters and Key Challenges  The growth of the  Blood Screening Market  is the result of the rise in the screening of donor and consistent technological advancement by the industry participants. Demand for blood screening tests has been on the rise in recent years owing to the surge in donation, boosted awareness about transfusion-transmitted diseases, and technological advancements within the industry. In addition, governments in several countries are striving to mandate testing of all the donated blood for a number of viruses. Technological developments help enhance the sensitivity and efficiency of the tests. Case in point, in 2016, the Procleix Zika virus assay developed by Hologic, Inc., and Grifols was approved by the U.S. F.D.A for screening of donated blood. Moreover, in 2013, the U.S. FDA had given approval to the